Cargando…
Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
Specimens of formalin-fixed, paraffin-embedded non-small-cell lung carcinomas (NSCLCs; n = 187) were analysed immunohistochemically for expression of cyclin A. The analysis was intended to determine whether cyclin A has additional prognostic value for predicting patients' survival and drug resp...
Autores principales: | Volm, M., Koomägi, R., Mattern, J., Stammler, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223613/ https://www.ncbi.nlm.nih.gov/pubmed/9192980 |
Ejemplares similares
-
Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.
por: Volm, M., et al.
Publicado: (1991) -
Protein expression profiles indicative for drug resistance of non-small cell lung cancer
por: Volm, M, et al.
Publicado: (2002) -
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.
por: Mattern, J., et al.
Publicado: (1996) -
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
por: Volm, M., et al.
Publicado: (1998) -
Development of drug resistance in a human epidermoid lung carcinoma xenograft line.
por: Mattern, J., et al.
Publicado: (1988)